$ImmunityBio, Inc.(IBRX)$
Watch them flock to secure a buyout.
Their market cap should be at least $100 billion , especially when you consider the cancer treatment is 2x more effective than the likes of Merck....
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
